Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Larson

Showing results (231-240 of 234) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 234 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2022
Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) VaccinesNusrat J Epsi, Stephanie A Richard, David A Lindholm, et al.
Cell Host & Microbe|November 10, 2022
Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination historyWei Wang, Sabrina Lusvarghi, Rahul Subramanian, et al.
Organic Letters|October 30, 2025
Asymmetric Synthesis of MK-7845, an Investigational Treatment for COVID-19Reed T Larson, Ben W H Turnbull, Patrick J Moon, et al.
Journal of the American Chemical Society|March 24, 2025
Total Synthesis of Enlicitide DecanoateHongming Li, David A Thaisrivongs, Gao Shang, et al.
Pageof 24

Showing results (231-240 of 234) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 234 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2022
Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) VaccinesNusrat J Epsi, Stephanie A Richard, David A Lindholm, et al.
Cell Host & Microbe|November 10, 2022
Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination historyWei Wang, Sabrina Lusvarghi, Rahul Subramanian, et al.
Organic Letters|October 30, 2025
Asymmetric Synthesis of MK-7845, an Investigational Treatment for COVID-19Reed T Larson, Ben W H Turnbull, Patrick J Moon, et al.
Journal of the American Chemical Society|March 24, 2025
Total Synthesis of Enlicitide DecanoateHongming Li, David A Thaisrivongs, Gao Shang, et al.
Pageof 24